<VariationArchive RecordType="classified" VariationID="15899" VariationName="NG_012651.1:g.=" VariationType="Duplication" Accession="VCV000015899" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-08-11" DateCreated="2019-09-29" MostRecentSubmission="2019-09-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="30938" VariationID="15899">
      <GeneList>
        <Gene Symbol="HP" FullName="haptoglobin" GeneID="3240" HGNC_ID="HGNC:5141" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>16q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="72054505" stop="72061055" display_start="72054505" display_stop="72061055" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="72088507" stop="72094954" display_start="72088507" display_stop="72094954" Strand="+" />
          </Location>
          <OMIM>140100</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_012651.1:g.=</Name>
      <VariantType>Duplication</VariantType>
      <OtherNameList>
        <Name>Hp2</Name>
        <Name>1.7-KB DUP</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012651.1" sequenceAccession="NG_012651" sequenceVersion="1" change="g.=">
            <Expression>NG_012651.1:g.=</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="140100.0002" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">1.7-kb Hp2 duplication</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_012651.1:g.= AND Haptoglobin, alpha-2" Accession="RCV000017245" Version="24">
        <ClassifiedConditionList TraitSetID="5165">
          <ClassifiedCondition DB="MedGen" ID="C4016146">Haptoglobin, alpha-2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1993-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1993-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-09-29" MostRecentSubmission="2019-09-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8225317</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2880559</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">4172407</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5165" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Haptoglobin, alpha-2</ElementValue>
              </Name>
              <XRef ID="C4016146" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37517" SubmissionDate="2019-09-26" DateLastUpdated="2019-09-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="140100.0002_HAPTOGLOBIN, ALPHA-2" title="HP, 1.7-KB DUP_HAPTOGLOBIN, ALPHA-2" />
        <ClinVarAccession Accession="SCV000037517" DateUpdated="2019-09-29" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">The alpha-2 chain originated through a chromosomal aberration (unequal crossingover) in a person who was heterozygous alpha-1F/alpha-1S. The alpha-2 chain is nearly twice as long as the alpha-1 chain and consists of portions of alpha-1F and alpha-1S (Black and Dixon, 1968). The HP*2 allele has an internal duplication of 1.7 kb that includes 2 of the alpha-chain exons. The HP2-alpha polypeptide consists of 142 amino acids, while the HP1-alpha polypeptide has 83 amino acids (Maeda, 1991). Marles et al. (1993) showed that homologous crossingover between HP*2 and either an HP*1F or HP*1S allele in HP*2/HP*1 heterozygotes can change the usual type of HP*2 to 3 other forms: HP*2SS, HP*2FF, or HP*2SF. Marles et al. (1993) described a nuclear family in which the uncommon genotype HP*2SS in one parent caused initial confusion in assigning genotypes to the rest of the nuclear family.</Attribute>
              <Citation>
                <ID Source="PubMed">4172407</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2880559</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8225317</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HP" />
          </GeneList>
          <Name>HP, 1.7-KB DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1.7-KB DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="140100.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HAPTOGLOBIN, ALPHA-2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37517" TraitType="Disease" MappingType="Name" MappingValue="HAPTOGLOBIN, ALPHA-2" MappingRef="Preferred">
        <MedGen CUI="C4016146" Name="Haptoglobin, alpha-2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

